[Effects of bcl-2 antisense oligodeoxynucleotide on proliferation and apoptosis of Raji cells]

Fu-xu Wang1, Zuo-ren Dong, Ze-lin Liu

  • 1Department of Hematology, The Second Affiliated Hospital of Hebei Medical University, Shijiazhuang 050000, China.

Abstract

Insights

Antisense oligodeoxynucleotides targeting bcl-2 (bcl-2 ASODN) show antitumor effects by inducing apoptosis in malignant lymphoblastic cells. This therapy downregulates bcl-2 protein expression, offering a potential treatment strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Oligonucleotide Therapeutics

Context:

  • Malignant lymphoblastic cells are a significant challenge in oncology.
  • The bcl-2 protein plays a crucial role in inhibiting apoptosis.
  • Targeting bcl-2 offers a potential therapeutic strategy for cancer.

Purpose:

  • To investigate the in vitro antitumor activity of bcl-2 antisense oligodeoxynucleotide (bcl-2 ASODN).
  • To evaluate the effect of bcl-2 ASODN on proliferation and apoptosis of malignant lymphoblastic cells.
  • To assess the impact of bcl-2 ASODN on bcl-2 protein and mRNA expression.

Summary:

  • bcl-2 ASODN partially inhibited the growth of Raji cells.
  • Treatment with bcl-2 ASODN induced characteristic morphologic changes of apoptosis.
  • The apoptosis rate significantly increased in treated cells, accompanied by decreased bcl-2 mRNA expression.

Impact:

  • bcl-2 ASODN demonstrates in vitro antitumor activity against malignant lymphoblastic cells.
  • The mechanism involves the induction of apoptosis.
  • Downregulation of bcl-2 protein expression is key to this therapeutic effect.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...